Rick Martin, CEO of Microgen Diagnostics, discusses COVID-19 testing with E. David Crawford, MD. Mr. Martin explains the type of tests currently used around the world, how exactly the tests are administered, and why these tests are running into problems. He goes on to discuss how his company is developing a validated sputum-based test which is more accurate and more sensitive that can be ordered directly from the company then shipped directly to the patient’s home to avoid contact as much as possible, with results available through an online portal within a week.

свернуть